Form 4: Lemaitre Vascular Exec Sells Shares After Option Exercise

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, exercised stock options and subsequently sold the acquired shares.

Summary

• Trent G. Kamke, Senior V.P., Operations at LEMAITRE VASCULAR INC, exercised 2,625 stock options on March 11, 2026.
• The options were exercised at a price of $35.48 per share.
• Concurrently, Mr. Kamke sold 2,625 shares of LEMAITRE VASCULAR INC common stock on March 11, 2026.
• The shares were sold at a price of $108.50 per share.
• Following these transactions, Mr. Kamke directly owns 6,677 shares of common stock.
• Mr. Kamke also directly owns 1,353 stock options after the reported transactions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a standard executive compensation transaction rather than a signal of company performance or strategic shift.

Positives

• The Senior VP of Operations realized a significant profit by exercising options at $35.48 and selling shares at $108.50, indicating a successful personal investment outcome.

Negatives

• A Senior VP of Operations sold 2,625 shares of company common stock, which some investors might interpret as a slight negative, even if part of a pre-planned compensation strategy.

Risks

• Insider selling by a Senior VP of Operations, even if routine, could be perceived by some investors as a potential lack of confidence in the company's near-term prospects, though this transaction appears to be a standard exercise-and-sell.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as this exercise and sale, are common events in publicly traded companies, often related to executive compensation plans or personal financial planning, and do not inherently reflect broader industry trends.

Related Party Transactions

• Trent G. Kamke, Senior V.P., Operations, exercised stock options and sold shares of LEMAITRE VASCULAR INC, which constitutes a transaction by a related party (company officer).

Stakeholder Impact

• Shareholders: May observe the insider sale, which could be interpreted in various ways, though it is often a routine part of executive compensation and personal financial management.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

LEMAITRE VASCULAR, LMAT, insider trading, Form 4, stock options, share sale, executive compensation